Patients with heart failure (HF) exhibited a higher prevalence of atrial fibrosis [3], and mineralocorticoid receptor antagonist treatment decreases the incidence of new-onset AF in patients with HF [4]. Here, NR3C2 is linked to hydrops fetalis.